News and Trends 4 Sep 2024
2024: a year of breakthroughs for endometrial cancer?
New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.
Don't miss out on the next big biotech breakthrough
Get all the latest updates straight into your inbox!
Newsletter Signup - Home CTA
"*" indicates required fields
-
News and TrendsSeptember 6, 2024Psychedelic therapies under scrutiny: What’s next after Lykos’ MDMA rejection?
-
PodcastSeptember 6, 2024The power of tumor infiltrating lymphocyte to fight melanoma
-
In DepthSeptember 5, 2024The biggest private biotech investments in August 2024
-
Best in BiotechSeptember 5, 2024Six biotech companies that could revolutionize obesity treatments
- Latest Posts
- Popular Posts
In Depth 3 Sep 2024Adaptimmune: The long road toward finally bringing the first TCR-T cell therapy to the market
Find out about Adaptimmune’s long – and somewhat bumpy – road toward bringing the first TCR-T therapy to the market.
The crucial role of GS-CHO innovation in biopharmaceutical progress
Learn how GS-CHO systems are advancing to improve yields and quality in biomanufacturing, meeting the rising need for effective therapeutic proteins.
News and Trends 2 Sep 2024Are we in an AI bubble? Biotech AI startups’ value plummet and leads to restructuration
Delve into the downturn AI is experiencing in biotech: Is the bubble bursting or is the market correcting the high expectations?
Podcast 30 Aug 2024The future of combination vaccines
To look at combination vaccines, listen to our conversation with Cesar Sanz Rodriguez, vice president, Europe & Switzerland, medical affairs, at Moderna.
Best in Biotech 29 Aug 2024Eight biotech companies you should know about in Spain
Take a look at some of the top biotech companies you can find in Spain, whose biotech industry has grown dramatically in the last decade.ADVERTISEMENT
ADVERTISEMENT
News and Trends 28 Aug 2024GLP-1 shortage: Can biotech companies keep up with rising demand?
How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question.
Navigating your path to globalization: Untangling the regulatory maze of the Advanced Therapies supply chain
Discover how Cryoport Systems can help you navigate EMEA regulations and manage the supply chain complexities for advanced therapies.
News and Trends 27 Aug 2024Could microbiome drugs be the key to unlocking checkpoint inhibitors’ potential?
As Microbiotica announces phase 1 approval for two microbiome drugs we delve into their potential in oncology and beyond.
Podcast 23 Aug 2024New German biotech spins out to develop radiotherapeutics
While it is currently owned by the Eckert & Ziegler Group, Pentixapharm will soon be spun off as a separate company. Listen to our conversation with Andreas Eckert, founder of the company
Best in Biotech 22 Aug 2024Seven companies transforming the biotech industry in Italy
Delve into Italy’s biotech landscape with seven companies that are leading the charge in the European country.
In Depth 21 Aug 2024The promise of antisense oligonucleotides in precision medicine
Find out all about antisense oligonucleotides, which have gained a lot of popularity in recent years and could treat numerous diseases.
Expert Advice 2 Feb 20245 biotech career paths where demand is skyrocketing
Check out five important biotechnology careers that are currently in high demand, and likely still will be in the coming years.
Best in Biotech 12 Mar 2024The twelve hottest biotech companies in the Boston area
Explore Boston’s vibrant biotech landscape with twelve innovative companies leading the charge in life sciences research.
In Depth 12 Feb 2024RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?
Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time.
In Depth 15 Jan 2024The future of diabetes treatment: Is a cure possible?
Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we?
In Depth 8 Feb 2024Could we see a new dawn for hair loss treatments?
Discover the latest advances in hair loss treatments, from topical therapies to the the groundbreaking potential of JAK inhibitors.
Best in Biotech 5 Jan 2024Five AI drug discovery companies you should know about
Take a look at five of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process.
Expert Advice 15 Mar 2024Is biotechnology a good career? Here are the pros and cons
Find out about the pros and cons of pursuing a career in biotechnology, from competitive salaries to dealing with regulatory hurdles.
In Depth 9 Feb 2024Biotech job market 2024: what to expect?
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?
Podcast 19 Jan 2024Epigenetic editing – the power of CRISPR without cutting DNA
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]
Best in Biotech 12 Apr 20246 biotechnology universities in the US nurturing tomorrow’s trailblazers
Discover the top biotechnology universities in the US offering cutting-edge programs that are helping students find a career in biotech.
In Depth 8 Jul 2024Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR
Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique.
Best in Biotech 13 Feb 2024Eight biotechs thriving in Seattle
In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.
ADVERTISEMENT